Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Perfuze

Perfuze Announces Final MARRS Results: Strong Reperfusion and First-Pass Performance in Pivotal Stroke Trial

August 31, 2026

From Perfuze

Via Business Wire

Perfuze Receives FDA Clearance for Millipede88® — the First Super-Bore Aspiration Catheter Cleared for Standalone Direct Aspiration

March 17, 2026

From Perfuze

Via Business Wire

Perfuze Presents Preliminary Results from MARRS Pivotal Trial at SNIS, Highlighting Millipede88 Performance in Acute Ischemic Stroke

July 16, 2025

From Perfuze

Via Business Wire

Perfuze Announces Completion of Enrollment in Pivotal US Clinical Study and Appointment of Joe Rotger as Executive Vice President of Sales

April 22, 2025

From Perfuze

Via Business Wire

Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding

March 13, 2025

From Perfuze

Via Business Wire

Perfuze® Announces FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment

December 20, 2023

From Perfuze

Via Business Wire

Perfuze® Announces First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial for the Millipede System

November 02, 2023

From Perfuze

Via Business Wire

Perfuze Announces Appointment of New Chair of the Board

June 09, 2023

From Perfuze

Via Business Wire

Perfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter

February 16, 2023

From Perfuze

Via Business Wire

Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment

February 09, 2022

From Perfuze

Via Business Wire

Perfuze Announces CE Mark and First Patients Treated with the Millipede 088

May 04, 2021

From Perfuze

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.